These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34692494)

  • 21. Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI.
    Cramer SP; Simonsen H; Frederiksen JL; Rostrup E; Larsson HB
    Neuroimage Clin; 2014; 4():182-9. PubMed ID: 24371801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-Brain Barrier Permeability in Patients With Reversible Cerebral Vasoconstriction Syndrome Assessed With Dynamic Contrast-Enhanced MRI.
    Wu CH; Lirng JF; Wu HM; Ling YH; Wang YF; Fuh JL; Lin CJ; Ling K; Wang SJ; Chen SP
    Neurology; 2021 Nov; 97(18):e1847-e1859. PubMed ID: 34504032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
    Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
    Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal Cerebral Microbleeds Are Associated With Radiation Necrosis and Cognitive Dysfunction in Patients Treated for Nasopharyngeal Carcinoma.
    Shen Q; Lin F; Rong X; Yang W; Li Y; Cai Z; Xu P; Xu Y; Tang Y
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1113-20. PubMed ID: 27026315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature.
    Delishaj D; Ursino S; Pasqualetti F; Cristaudo A; Cosottini M; Fabrini MG; Paiar F
    J Clin Med Res; 2017 Apr; 9(4):273-280. PubMed ID: 28270886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage.
    Huang B; Wong CS; Whitcher B; Kwong DL; Lai V; Chan Q; Khong PL
    Eur Radiol; 2013 Jun; 23(6):1495-502. PubMed ID: 23377545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
    Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality of early treatment for radiation-induced brain necrosis in head and neck cancer survivors: A multicentre, retrospective, registry-based cohort study.
    Pan D; Rong X; Chen D; Jiang J; Ng WT; Mai H; Li Y; Li H; Cai J; Cheng J; Xu Y; Chua MLK; Simone CB; Lattanzi S; Tang Y
    EClinicalMedicine; 2022 Oct; 52():101618. PubMed ID: 36034411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
    Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
    J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-Dosage Bevacizumab Treatment: Effect on Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases.
    Weng Y; Shen J; Zhang L; Fang Z; Xiao F; Zhang C; Fan Z; Huang K; Wang L; Huang B; Wu F; Zhang T; Xu Q
    Front Surg; 2021; 8():720506. PubMed ID: 34540887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Contrast-enhanced MRI Quantification of Altered Vascular Permeability in Autoimmune Encephalitis.
    Ji SH; Yoo RE; Choi SH; Lee WJ; Lee ST; Jeon YH; Choi KS; Lee JY; Hwang I; Kang KM; Yun TJ
    Radiology; 2024 Mar; 310(3):e230701. PubMed ID: 38501951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound.
    Park J; Zhang Y; Vykhodtseva N; Jolesz FA; McDannold NJ
    J Control Release; 2012 Aug; 162(1):134-42. PubMed ID: 22709590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis.
    Hirashima Y; Yamada Y; Tateishi U; Kato K; Miyake M; Horita Y; Akiyoshi K; Takashima A; Okita N; Takahari D; Nakajima T; Hamaguchi T; Shimada Y; Shirao K
    Int J Cancer; 2012 May; 130(10):2359-65. PubMed ID: 21780098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative assessment of vasculature with DCE-MRI in nasopharyngeal carcinomas following radiotherapy and its value for efficacy evaluation].
    Liao W; Yang L; Jiang W; Sun L; Cao Y; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):954-9. PubMed ID: 26198942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic contrast-enhanced (DCE) MRI derived kinetic perfusion indices may help predicting seizure control in single calcified neurocysticercosis.
    Singh AK; Garg RK; Gupta RK; Malhotra HS; Agrawal GR; Husain N; Pandey CM; Sahoo P; Kumar N
    Magn Reson Imaging; 2018 Jun; 49():55-62. PubMed ID: 29366682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in blood-brain barrier leakage in healthy, older adults.
    Verheggen ICM; de Jong JJA; van Boxtel MPJ; Gronenschild EHBM; Palm WM; Postma AA; Jansen JFA; Verhey FRJ; Backes WH
    Geroscience; 2020 Aug; 42(4):1183-1193. PubMed ID: 32601792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases.
    Glitza IC; Guha-Thakurta N; D'Souza NM; Amaria RN; McGovern SL; Rao G; Li J
    Melanoma Res; 2017 Dec; 27(6):580-584. PubMed ID: 28817446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report.
    Liu R; Luo H; Zhang Q; Sun S; Liu Z; Wang X; Geng Y; Zhao X
    Mol Clin Oncol; 2022 Jul; 17(1):114. PubMed ID: 35747599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cluster-based radiomics reveal spatial heterogeneity of bevacizumab response for treatment of radiotherapy-induced cerebral necrosis.
    Tan HQ; Cai J; Tay SH; Sim AYL; Huang L; Chua MLK; Tang Y
    Comput Struct Biotechnol J; 2024 Dec; 23():43-51. PubMed ID: 38125298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The correlation between serum apolipoprotein B/apolipoprotein A1 ratio and brain necrosis in patients underwent radiotherapy for nasopharyngeal carcinoma.
    Li H; Zheng D; Xie F; Huang X; Zhuo X; Lin J; Li Y; Tang Y
    Brain Behav; 2020 Mar; 10(3):e01554. PubMed ID: 32017458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.